Anti-ARID5A antibody produced in rabbit
SIGMA/HPA023879 - Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Synonym: Anti-ARID domain-containing protein 5A; Anti-AT-rich interactive domain-containing protein 5A; Anti-MRF-1; Anti-Modulator recognition factor 1
Product Type: Chemical
ChIP-Exo-Seq composite graph for Anti-ARID5A (HPA023879, Lot 000024429) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University. *Please note not all antibody batches are validated for use in ChIP applications.
Immunohistochemistry Immunohistochemical staining of human urinary bladder shows strong nuclear positivity in urothelial cells.
Immunohistochemistry Immunohistochemical staining of human prostate shows moderate nuclear positivity in glandular cells.
Immunohistochemistry Immunohistochemical staining of human cerebral cortex shows strong nuclear positivity in neurons.
Immunohistochemistry Immunohistochemical staining of human fallopian tube shows moderate nuclear positivity in glandular cells.
Immunofluorescence Immunofluorescent staining of human cell line A-431 shows positivity in nucleus & nucleoli.
Western Blotting Western blot analysis in human cell line HDLM-2.
| antibody form | affinity isolated antibody |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| conjugate | unconjugated |
| form | buffered aqueous glycerol solution |
| immunogen sequence | LVLPYVRHLKGEDDKPLPTSKPRKQ |
| product line | Prestige Antibodies® Powered by Atlas Antibodies |
| Quality Level | 100  |
| shipped in | wet ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | ChIP: 1—10 μg (per reaction) |
| immunoblotting: 0.04-0.4 μg/mL | |
| immunofluorescence: 0.25-2 μg/mL | |
| immunohistochemistry: 1:1000-1:2500 | |
| UniProt accession no. | Q03989  |
| Application: | All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies® protocols and other useful information. |
| Biochem/physiol Actions: | AT-rich interactive domain (ARID)-containing protein 5A (Arid5a), in association with transcription factor SRY-box containing gene 9 (Sox9), plays a role in activation of chondrocyte-specific transcription. It also takes part in stabilization of IL-6 mRNA. Arid5a, along with other members of ARID protein family, plays vital role in development, tissue specific gene expression and proliferation. Arid5a/modulator recognition factor 1 (MRF1)protein regulates ER-dependent gene expression in cardiovascular and other cells. |
| Features and Benefits: | Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section. Every Prestige Antibody is tested in the following ways: • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues. • Protein array of 364 human recombinant protein fragments. |
| General description: | AT-rich interactive domain (ARID)-containing protein 5A (Arid5a), also known as modulator recognition factor 1 (MRF1), is a member of ARID protein family. The protein consists of helix-turn-helix motif DNA-binding domain called ARID, which binds to specific AT-rich DNA sequences. Arid5a or MRF1 is highly expressed in aorta, heart, skeletal muscle, and liver. Chlorpromazine (CPZ) acts as an inhibitor of Arid5a. |
| Immunogen: | AT-rich interactive domain-containing protein 5A recombinant protein epitope signature tag (PrEST) |
| Legal Information: | Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany |
| Other Notes: | Corresponding Antigen APREST86209 |
| Physical form: | Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |